Patents by Inventor Yuelei DU

Yuelei DU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240145321
    Abstract: A substrate integrated with passive devices and a manufacturing method thereof are provided.
    Type: Application
    Filed: April 23, 2021
    Publication date: May 2, 2024
    Inventors: Chuncheng CHE, Feng LIU, Yuelei XIAO, Yue LI, Guochen DU, Xue CAO, Yifan WU, Wenbo CHANG
  • Patent number: 11466005
    Abstract: Disclosed are tricyclic compounds as bromodomain and extra-terminal (BET) inhibitors which are shown as formula I, their synthesis and their use for treating diseases. More particularly, disclosed are fused heterocyclic derivatives useful as inhibitors of BET, methods for producing such compounds and methods for treating diseases and conditions wherein inhibition of one or more BET bromodomains provides a benefit.
    Type: Grant
    Filed: December 23, 2021
    Date of Patent: October 11, 2022
    Assignee: JACOBIO PHARMACEUTICALS CO., LTD.
    Inventors: Haiquan Fang, Mingming Chen, Guiqun Yang, Yuelei Du, Yanping Wang, Tong Wu, Qinglong Li, Lei Zhang, Shaojing Hu
  • Publication number: 20220119390
    Abstract: Disclosed are tricyclic compounds as bromodomain and extra-terminal (BET) inhibitors which are shown as formula I, their synthesis and their use for treating diseases. More particularly, disclosed are fused heterocyclic derivatives useful as inhibitors of BET, methods for producing such compounds and methods for treating diseases and conditions wherein inhibition of one or more BET bromodomains provides a benefit.
    Type: Application
    Filed: December 23, 2021
    Publication date: April 21, 2022
    Inventors: Haiquan FANG, Mingming CHEN, Guiqun YANG, Yuelei DU, Yanping WANG, Tong WU, Qinglong LI, Lei ZHANG, Shaojing HU
  • Publication number: 20210179617
    Abstract: Disclosed are tricyclic compounds as bromodomain and extra-terminal (BET) inhibitors which are shown as formula I, their synthesis and their use for treating diseases. More particularly, disclosed are fused heterocyclic derivatives useful as inhibitors of BET, methods for producing such compounds and methods for treating diseases and conditions wherein inhibition of one or more BET bromodomains provides a benefit.
    Type: Application
    Filed: December 22, 2020
    Publication date: June 17, 2021
    Inventors: Haiquan FANG, Mingming CHEN, Guiqun YANG, Yuelei DU, Yanping WANG, Tong WU, Qinglong LI, Lei ZHANG, Shaojing HU